Dose Unit
Showing 1 - 25 of >10,000
Hypotension Trial (Epinephrine 0.5 mcg/kg, Epinephrine 1 mcg/kg)
Enrolling by invitation
- Hypotension
- Epinephrine 0.5 mcg/kg
- Epinephrine 1 mcg/kg
-
Boston, MassachusettsBoston Children's Hospital
Feb 1, 2023
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Healthy Participants Trial in New Haven, Brussels (PF-07321332 Dose 1, PF-07321332 Dose 2, PF-07321332 Dose 3)
Completed
- Healthy Participants
- PF-07321332 Dose 1
- +5 more
-
New Haven, Connecticut
- +1 more
Sep 8, 2022
Myopia Trial in Assiut (Preservative-free Benoxinate HCl 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind.,
Completed
- Myopia
- Preservative-free Benoxinate hydrochloride 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt)
- Preservative-free Sodium hyaluronate 0.2% (Polyfresh unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt).
-
Assiut, EgyptTiba Eye Center
Feb 8, 2023
Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)
Recruiting
- Healthy Adults
- Adagrasib
- Eltrombopag + adagrasib
-
Daytona Beach, FloridaFortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023
Chemo-induced Diarrhea Trial in Glendale (SK10, Placebo)
Recruiting
- Chemotherapy-induced Diarrhea
- SK10
- Placebo
-
Glendale, CaliforniaEarly Phase Clinical Unit (EPCU) - PAREXEL
Aug 30, 2023
Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence Trial (Botox 50 Unit Injection, Botox 100 Unit
Not yet recruiting
- Overactive Bladder
- +2 more
- Botox 50 Unit Injection
- Botox 100 Unit Injection
- (no location specified)
Aug 19, 2022
Acute Respiratory Failure Trial in Paris (Chlorhydrate de morphine, NaCl 0,9%,)
Completed
- Acute Respiratory Failure
- Chlorhydrate de morphine
- NaCl 0,9%,
-
Paris, FranceGroupe Hospitalier Pitié Salpetriere
Oct 24, 2022
Healthy Trial in Christchurch (LTG-001, Placebo)
Not yet recruiting
- Healthy
- LTG-001
- Placebo
-
Christchurch, New ZealandClinical Research Unit
Sep 21, 2023
Coagulopathy, Hemorrhage Trial in Cincinnati (Autologous Spray Dried Plasma)
Not yet recruiting
- Coagulopathy
- Hemorrhage
- Autologous Spray Dried Plasma
-
Cincinnati, OhioHoxworth Blood Center
Nov 29, 2022
Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)
Active, not recruiting
- Alcohol Use Disorder
- DCR-AUD
- Placebo
-
Glendale, CaliforniaParexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023
SARS-CoV, SARS-CoV-2 Trial in Durban, Soweto (VXCO-100, COVID-19 mRNA vaccine and VXCO-100, COVID-19 mRNA vaccine)
Not yet recruiting
- SARS-CoV
- SARS-CoV-2
- VXCO-100
- +2 more
-
Durban, South Africa
- +1 more
Jul 5, 2023
Psychiatric Disorders, Insomnia Trial in Copenhagen NV (Melatonin, Quetiapine, Placebo)
Recruiting
- Psychiatric Disorders
- Insomnia
- Melatonin
- +2 more
-
Copenhagen NV, DenmarkMental Health Center Copenhagen
Sep 25, 2023
Healthy Participants Trial in Cincinnati (Olezarsen)
Recruiting
- Healthy Participants
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Nov 29, 2022
Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP
Not yet recruiting
- Influenza
- Influenza Virus Quadrivalent Inactivated Vaccine
- +2 more
-
Durham, North CarolinaDuke Human Vaccine Institute - Duke Vaccine and Trials Unit
Feb 23, 2023
Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)
Recruiting
- Healthy Participants
- CK-3828136
- Placebo for CK-3828136
-
Dallas, TexasLabcorp Clinical Research Unit Inc.
Dec 20, 2022
Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)
Not yet recruiting
- Healthy
- Atopic Dermatitis
- LY3872386
- +2 more
-
Daytona Beach, FloridaFortrea Clinical Research Unit
Nov 1, 2023
Pneumonia Trial in Alor Setar, Kota Bharu, Ipoh (Active Ingredient, Placebo)
Not yet recruiting
- Pneumonia
- Active Ingredient
- Placebo
-
Alor Setar, Kedah, Malaysia
- +2 more
Apr 24, 2023
Sepsis, Severe, Septic Shock Trial in Melbourne (Sodium Ascorbate)
Recruiting
- Sepsis, Severe
- Septic Shock
- Sodium Ascorbate
-
Melbourne, Victoria, AustraliaIntensive Care Unit Royal Melbourne Hospital
Nov 2, 2022